0.28
-3.45%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Somnomed
Its shares trade on ASX under the ticker SOM.AX. It has been listed since 27 August 2004. In the fiscal year to 30 June 2026, it reported revenue of A$114.5m and a net loss of A$2.6m. At that date it held total assets of A$75.0m and shareholders' equity of A$47.4m.
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm's products include SomnoDent Fusion, SomnoDent Flex, SomnoDent Classic, Somnodent SUAD, Somnodent SUAD Ultra, SomnoDent Herbst Advance, SomnoDent AIR & AIR+ and Morning Repositioner. The SomnoDent Herbst Advance is an intraoral device featuring a visual calibration indicator for the treatment of obstructive sleep apnea (OSA). The firm manufactures custom fit acrylic occlusal splints (dental guards), the SomnoBrux, to protect patient's teeth against heaving grinding and bruxism. Its SomnoBrux products include Gelb, Tanner and Michigan. The company offers SOMGauge, which is an autoclavable instrument that can be used to construct reliable bite records. The firm provides medical reimbursement services to assist dental offices with submitting a medical claim for their patients' OSA treatment.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 27 Aug 2004
- Employees
- 300
- Website
- somnomed.com.au ↗
Leadership
Pay as last reported
- Mr. Guy RussoNon-Executive Chairman of the BoardA$184,227
- Ms. Amrita BlicksteadJoint Co-Chief Executive Officer, Executive Director, since 2020A$90,978
- Ms. Karen BorgJoint Co-Chief Executive Officer, Executive Director, since 2020A$90,978
- Ms. Ye-fei GuoChief Financial Officer
- Mr. Matthew ConlonExecutive Vice President – Marketing and Sales North AmericaA$569,191
- Mr. Jonathan VowelsVice President - Manufacturing and Operations
- Mr. Mark HardingVice President - Global MarketingA$490,938
- Mr. Marco Van KleefVice President – Marketing & Sales EuropeA$320,031
- Mr. Terence FlitcroftCompany Secretary, since 1995A$35,377
- Mr. Andrew PriceDirector
- Mr. Benjamin GiszNon-Executive Director
- Mr. Michael GordonNon-Executive DirectorA$92,113
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Somnomed Ltd has several strengths that give it a competitive advantage in the market. These strengths include:
Weaknesses
- Despite its strengths, Somnomed Ltd also faces certain weaknesses that could hinder its growth and performance. These weaknesses include:
Opportunities
- Somnomed Ltd can capitalize on various opportunities in the market to further expand its business. These opportunities include:
Threats
- However, Somnomed Ltd also faces threats that may pose challenges to its growth and sustainability. These threats include:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.